Affiliation:
1. Shiraz University of Medical Sciences,Pharmaceutical Sciences Research Center,Shiraz,Iran,
2. Henan University of Science and Technology,Henan Key Laboratory of Environmental and Animal Product Safety,Henan,China,
Abstract
Several transporters have been identified for taurine (TAU) absorption from
the gastrointestinal (GI) tract. The Na+
/Cl-
-dependent taurine transporter (TauT) and
PAT1 (SLC36A1) are well-known TAU transporters in the GI. These transporters
efficiently deliver TAU from GI to the bloodstream. On the other hand, no metabolic
pathway has been identified for TAU in the human body. But, it has been found that
GI-resident bacteria are able to metabolize TAU to sulfur-containing chemicals (e.g.,
H2S). Hence, GI is the primary place for TAU metabolism. TAU-conjugated
compounds such as bile acids are also excreted through GI. Compounds such as H2S
could be re-absorbed from GI and have a tremendous physiological effect on other
organs (e.g., heart and vessels). Finally, it should be noted that several studies
mentioned that TAU could protect GI in various pathological conditions (e.g.,
xenobiotics-induced GI damage). In the current chapter, a brief review of the
absorption, metabolism, and excretion of TAU is provided. Then, the importance of
TAU metabolites in the GI and other organs is highlighted. Finally, the effects of TAU
on GI complications are discussed, focusing on the effects of this amino acid on
oxidative stress biomarkers and mitochondrial impairment. These data could give a
new concept of the physiological roles of TAU as well as its effects on GI
complications.<br>
Publisher
BENTHAM SCIENCE PUBLISHERS